Urinary Tract Carcinoma — Trials

Urinary Tract Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

852 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 326
Recruiting: 177
Ph III recruiting: 26
Growth YoY: +28.6%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 44.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (127)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04502095	Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy	completed	Phase 4	89	Roswell Park Cancer InstituteOTHER	1	Sep 29, 2026	clinicaltrials
NCT04197089	Biological Effect of Vitamin D in Patients With Urothelial Carcinoma(VitDURO)	completed	Phase 4	2	Germans Trias i Pujol HospitalOTHER	1	Aug 3, 2022	clinicaltrials